Encorafenib,Cetuximab,Binimetinib
Pfizer,Eli Lilly,Array Biopharma
['colorectal', 'triplete', 'beacon', 'rectal']
 genomic mechanisms of acquired resistance in mbraf v600e #colorectalcance in beacon at emso22 by 320 pts -&gt; ctdna guardantomni doublet: mutations in ras-mek signaling triplete: enhanced receptor signaling 
Physician-scientist, focused on translational research in hepatobiliary cancer and precision medicine